—Arxada makes a second acquisition “” Arxada, the Lonza specialty chemical business purchased in July by the private equity firms Bain Capital and Cinven, has acquired the biocide specialist Enviro Tech Chemical Services for an undisclosed sum. Enviro Tech is a major producer of peracetic acid, viewed as an environmentally sustainable alternative to chlorine in industries such as food and beverage sanitation.
by Alexander H. Tullo | January 02, 2022
—Cambrex strikes again with acquisition of Avista “” Continuing a string of acquisitions, Cambrex has agreed to acquire Avista Pharma Solutions for $252 million. Avista is owned by Ampersand Capital Partners and operates three facilities in the U.S. and one in Scotland. It engages in a range of pharmaceutical services, including early-stage small-molecule development and testing as well as finished-dosage services. The deal follows Cambrex’s acquisition of Halo Pharma earlier this year, which added final-dosage services to Cambrex’s offerings. /business/mergers-&-acquisitions/Cambrex-strikes-again-acquisition-Avista/96/i47 20181122 Concentrates 96 47 /magazine/96/09647.html Cambrex strikes again with acquisition of Avista Specialty chemicals, Cambrex con bus Rick Mullin business mergers-&-acquisitions Cambrex strikes deal for Avista Chemical & Engineering News Cambrex strikes again with acquisition of Avista Cambrex strikes again with acquisition of Avista
by Rick Mullin | November 22, 2018
—mRNA giants make acquisitions “” Two of the pandemic’s most well-recognized messenger RNA (mRNA) vaccine developers have begun the new year with acquisitions. For $85 million, Moderna will purchase Japan-based OriCiro Genomics, which specializes in cell-free DNA synthesis and amplification technology.
by Shi En Kim | January 12, 2023
—Aceto continues acquisition binge “” Aceto has acquired the affiliated companies Biotron Laboratories and Talus Mineral, which make ingredients for the nutritional supplement industry. Based in Salt Lake City, the firms specialize in mineral chelates using an amino acid–based chelation process. Aceto has bought several small firms in the pharmaceutical ingredient and specialty material sectors since the beginning of 2021, including Cascade Chemistry, Finar, and Syntor Fine Chemicals. /business/mergers-&-acquisitions/Aceto-continues-acquisition-binge/100/i9 20220306 Concentrates 100 9 /magazine/100/10009.html Aceto continues acquisition binge Nutrition, fine chemicals con bus Michael McCoy business mergers-&-acquisitions food food-ingredients Aceto continues acquisition binge Chemical & Engineering News Aceto continues acquisition binge Aceto continues acquisition binge
by Michael McCoy | March 06, 2022
—U.S. clears Bayer’s acquisition of Monsanto “” Bayer has cleared the last large antitrust hurdle on its path to finalize the $66 billion acquisition of Monsanto. On May 29, the U.S. Department of Justice gave the green light to the deal, provided that Bayer first wrap up its sale of $9 billion in seed and crop chemical businesses to German rival BASF.
by Melody M. Bomgardner | June 03, 2018
—Philip Morris adds to pharma unit with acquisition of inhaled-drug firm OtiTopic “ ” Philip Morris International continues its push into drug delivery with the acquisition of OtiTopic, a Los Angeles–based specialist in inhaled drugs. OtiTopic has an inhalable acetylsalicylic acid treatment called Asprihale in late-stage trials for myocardial infarction.
by Megha Satyanarayana | August 19, 2021
—Avantor completes VWR acquisition “” Avantor, a minnow in the laboratory supply business with about $700 million in annual sales, has completed its acquisition of VWR, a whale in the industry with $4.5 billion in sales. The combination, valued at $6.5 billion, will benefit from “deeper access to the high-growth biopharma, industrial, and applied research sectors,” says Avantor CEO Michael Stubblefield.
by Marc S. Reisch | November 27, 2017
—AMRI, now Curia, expands in biologics with two acquisitions “ ” The pharmaceutical services firm Albany Molecular Research Inc. (AMRI) has changed its name to Curia. At the same time, it is expanding beyond small-molecule services by acquiring the biologic drug service firm LakePharma and the biologic drug fill-and-finish service firm Integrity Bio.
by Rick Mullin | July 23, 2021
—Acquisition Unites Peroxide Producers “” United Initiators has acquired Syrgis Performance Initiators from Syrgis Performance Products for an undisclosed sum. United and SPI are private-equity-backed firms that produce organic peroxides used in polymer manufacturing and other applications. SPI had sales last year of about $50 million. United Initiators, a German company that was once part of Degussa, says the acquisition will bring its annual sales to more than $250 million. Dave Lamb, an executive with Vision Capital, United’s main owner, says his firm invested in United last year with an eye to consolidation in the organic peroxide sector. /articles/90/i34/Acquisition-Unites-Peroxide-Producers.html 20120820 Concentrates 90 34 /magazine/90/09034.html Acquisition Unites Peroxide Producers organic peroxides, acquisition, private equity con bus Michael McCoy business Acquisition Unites Peroxide Producers Chemical & Engineering News Acquisition Unites Peroxide Producers Acquisition Unites Peroxide Producers
by Michael McCoy | August 20, 2012
—Flavor Companies Get Acquisitive “” Two flavor and fragrance companies have made acquisitions. Frutarom Industries has acquired the Guatemalan flavor company Aroma for $12.5 million. Aroma, which serves food and beverage makers throughout Central America, represents Frutarom’s third acquisition this year in developing markets.
by Michael McCoy | December 02, 2013